Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Recurrence × fludarabine phosphate × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 9 Multiple Myeloma 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Lymphoma, Non-Hodgkin 6 Hodgkin Disease 6 Leukemia 4 Melanoma 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, Follicular 3 Leukemia, Biphenotypic, Acute 3 Hematologic Neoplasms 3 Anemia, Refractory, with Excess of Blasts 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Lymphoproliferative Disorders 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Lymphoma 2 Leukemia, Plasma Cell 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, B-Cell 2 Hematologic Diseases 2 Bone Marrow Failure Disorders 2 Adenocarcinoma of Lung 2 Vulvar Neoplasms 1

Interventions

Cyclophosphamide 10 fludarabine 8 Rituximab 8 Dexamethasone 8 pembrolizumab 7 venetoclax 5 glofitamab 5 Lenalidomide 5 obinutuzumab 4 Etoposide 4 Calcium Dobesilate 4 pomalidomide 3 Temozolomide 3 Doxorubicin 3 Cytarabine 3 zanubrutinib 2 tocilizumab 2 tisagenlecleucel 2 selinexor 2 ruxolitinib 2 ibrutinib 2 enzalutamide 2 dexamethasone acetate 2 dexamethasone 21-phosphate 2 carfilzomib 2 abemaciclib 2 Vincristine 2 Surgical Procedures, Operative 2 Radiotherapy 2 Prednisone 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡